ZYBERNO
Stock Report
Updated Sep 2, 2026

IMAC Holdings, Inc. (BACK)

Healthcare • OTC

$0.00

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
7.0/100
POOR BUSINESS
IMAC Holdings, Inc. (BACK) scores 7/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-2,428.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

IMAC Holdings, Inc. (BACK) stock report — Zyberno Score 7/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.00
Market Cap:$1.89K

Valuation Multiples (2)

P/S Ratio:0.03x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$4.87M
B. Profitability Assessment

Return Metrics (4)

ROA:-1,209.7%
Reinvestment Rate:2.2%
Fundamental Growth Rate (g):-52.5%

Margin Analysis (1)

Ebitda Margin:-10,651.9%

Yield Metrics (2)

Earnings Yield:-$1.41M
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:35.8%
Latest Earnings Filed:2025-12-17

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.02x
Quick Ratio:0.02x
Cash Ratio:0.00x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-7.67x
Times Interest Earned:-7.67

Capital Structure (4)

Working Capital:-12,976,880.00
Cash And Cash Equivalents:45,054.00
Long Term Debt:$0.00
Net Debt:$4.87M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $72.05K
Linear Growth: -50.0%
📊 Click to view full BACK Revenue analysis & methodology →
Cost Of Revenue Ttm:$451.47K

Profitability Breakdown (2)

-$372.45K-$8.58M

Bottom Line Performance (3)

-$12.45M
Income Before Tax:-$9.72M
Ebitda Ttm:-7,674,727.00

Operating Expenses (5)

Operating Expenses:8,161,377.00
R And D Expense:0.00
Sga Expense:7,563,478.00
Income Tax Expense:$0.00
Interest Expense:732,853.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:35,638.1%
Ebitda Margin:-10,651.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$310.06K
Current Assets:$310.06K
Ppe Net:800,294.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:13,286,935.00
Current Liabilities:13,286,935.00
Long Term Debt:$0.00
Short Term Debt:$4.91M

Equity & Capital (3)

Equity:-$12.98M
Retained Earnings:-$72.38M
Common Stock:120,000,000.00

Working Capital Items (3)

Accounts Receivable:28,030.00
Inventory:0.00
Accounts Payable:4,913,914.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:31,853.00
C. Cash Flow Analysis

Operating Activities (2)

-$3.99M$0.00

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$560.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:100,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:904,488.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-7.05
-$7.05
Earnings Per Share Ttm:-$3.29

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.02
Operating Cash Flow Per Share:-$0.84

Book Value & Capital (2)

Book Value Per Share:-$3.43
Cash Per Share:0.01

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.07x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:2.57x
Days Sales Outstanding Ttm:142.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:3,972.76
Cash Conversion Cycle:-4,829.76
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:2.2%
Fundamental Growth Rate (g):-52.5%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-50.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:BACK
Company Name:IMAC Holdings, Inc.
Sector:Healthcare
Industry:Services-Specialty Outpatient Facilities, NEC
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:3.78M
Shares Outstanding Basic:3.78M
Shares Outstanding Diluted:3.78M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-02 05:58:41 UTC
Data Timestamp:2026-08-24T18:27:20.899112
Scroll to Top